Maze Therapeutics (MAZE) Other Non-Current Assets (2024 - 2026)

Maze Therapeutics (MAZE) has 3 years of Other Non-Current Assets data on file, last reported at $1.1 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets changed 0.09% year-over-year to $1.1 million; the trailing twelve-month figure through Mar 2026 stood at $1.1 million (changed 0.09% YoY), and the FY2025 full-year result was $3.0 million, down 61.25% from the prior year.
• Other Non-Current Assets declined to $1.1 million in Q1 2026, from $3.0 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $7.9 million in Q4 2024 to a low of $1.1 million in Q1 2026.
• A 3-year average of $3.0 million and a median of $2.1 million in 2025 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets plunged 61.25% in 2025 and fell 0.09% in 2026, its largest moves.
• Tracing MAZE's Other Non-Current Assets over 3 years: stood at $7.9 million in 2024, then sank by 61.25% to $3.0 million in 2025, then slumped by 64.3% to $1.1 million in 2026.
• Business Quant data shows MAZE's Other Non-Current Assets at $1.1 million in Q1 2026, $3.0 million in Q4 2025, and $1.1 million in Q3 2025.